Israel resumes airdrop aid to Gaza after mass starvation warning
The military also said in a separate statement that designated humanitarian corridors would be established to enable the safe movement of United Nations convoys delivering aid to the Gaza population, and that humanitarian pauses would be implemented in densely populated areas.
'The airdrops will include seven pallets of aid containing flour, sugar, and canned food to be provided by international organisations,' it added.
Palestinian sources confirmed that aid has begun dropping in northern Gaza.
Israel has faced mounting criticism from aid agencies, which accuse it of restricting aid delivery. The World Health Organization (WHO) chief, Tedros Adhanom Ghebreyesus, described the crisis as 'man-made mass starvation'.
Palestinians carry sacks of flour unloaded from a humanitarian aid convoy in Gaza City on Saturday. Photo: AP
Israel, which cut off all supplies to Gaza from the start of March and reopened it with new restrictions in May, says it is committed to allowing in aid but must control it to prevent it from being diverted by militants.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Standard
2 days ago
- The Standard
J-pop star Kenshin Kamimura's sexual assault case adjourned to Aug 13
'If the baby could speak, she would scream': the risky measures to feed small babies in Gaza
The Standard
2 days ago
- The Standard
'If the baby could speak, she would scream': the risky measures to feed small babies in Gaza
Newborns are placed in bed after being taken off incubators in Gaza's Al Shifa hospital after power outage, amid the ongoing conflict between Israel and the Palestinian Islamist group Hamas, in Gaza City, Gaza November 12, 2023 in this still image obtained by REUTERS./File Photo
South China Morning Post
5 days ago
- South China Morning Post
What people living with liver cancer wish they had known earlier about hepatitis B
Although extensive vaccination programmes have been in place since the 1980s, hepatitis B – a serious viral infection that attacks the liver – remains a major worldwide public health concern and the subject of continuing efforts to raise awareness about the importance of early diagnosis and treatment with timely, appropriate treatment. During the acute infection phase, it can cause a range of symptoms from mild to acute, lasting for up to six months, with the most common signs of the disease including nausea, fever, fatigue, abdominal pain, loss of appetite and jaundice. However, some cases can progress to a chronic infection and may eventually cause cirrhosis and liver cancer, typically leading to the need for costly long-term medical care. Liver cancer rates in Southeast Asia are expected to double by 2050, resulting in 200,000 deaths per year. The hepatitis B virus (HBV) is transmitted by exposure to infectious blood or body fluids – most commonly from mother to child during birth and delivery, particularly in highly endemic regions. Among the other risks are blood transfusions, dialysis and travel in countries with high rates of infection. Up to 254 million people were living with chronic hepatitis B in 2022, with a further 1.2 million new infections occurring each year, according to World Health Organization (WHO) estimates. These figures are striking, but it is often the experiences of individuals living day-to-day with the disease that most clearly bring home the urgent need for a wider call to action. Gilead Sciences, a biopharmaceutical company based in the United States, which specialises in the research and development (R&D) of antiviral drugs, is committed to raising awareness of the issue. It recently produced What I Wish I Knew, a short film series featuring four real-life stories of people living with hepatitis B in mainland China, Hong Kong, Taiwan and South Korea, which is both informative and inspiring.
